VIPoma historical perspective: Difference between revisions
Madhu Sigdel (talk | contribs) No edit summary |
Madhu Sigdel (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{VIPoma}} | {{VIPoma}} | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}{{AE}}{{MSI}}{{PSD}} | ||
==Overview== | ==Overview== | ||
VIPoma was first described in 1958 by Verner and Morrison.<ref name="pmid24251163">{{cite journal| author=Maheshwari RR, Desai M, Rao VP, Palanki RR, Namburi RP, Reddy KT et al.| title=Ischemic stroke as a presenting feature of VIPoma due to MEN 1 syndrome. | journal=Indian J Endocrinol Metab | year= 2013 | volume= 17 | issue= Suppl 1 | pages= S215-8 | pmid=24251163 | doi=10.4103/2230-8210.119576 | pmc=PMC3830309 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24251163 }} </ref> | VIPoma also known as Verner-Morrison syndrome was first described in 1958 by Verner and Morrison.<ref name="pmid24251163">{{cite journal| author=Maheshwari RR, Desai M, Rao VP, Palanki RR, Namburi RP, Reddy KT et al.| title=Ischemic stroke as a presenting feature of VIPoma due to MEN 1 syndrome. | journal=Indian J Endocrinol Metab | year= 2013 | volume= 17 | issue= Suppl 1 | pages= S215-8 | pmid=24251163 | doi=10.4103/2230-8210.119576 | pmc=PMC3830309 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24251163 }} </ref> | ||
==Historical Perspective== | ==Historical Perspective== | ||
VIPoma was first described in 1958 by John Verner and Ashton Morrison.<ref name="pmid24251163">{{cite journal| author=Maheshwari RR, Desai M, Rao VP, Palanki RR, Namburi RP, Reddy KT et al.| title=Ischemic stroke as a presenting feature of VIPoma due to MEN 1 syndrome. | journal=Indian J Endocrinol Metab | year= 2013 | volume= 17 | issue= Suppl 1 | pages= S215-8 | pmid=24251163 | doi=10.4103/2230-8210.119576 | pmc=PMC3830309 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24251163 }} </ref> | The neuroendocrine tumours of the gastrointestinal tract and pancreas were discovered after Rudolf Heidenhain first found out the neuroendocrine cells in 1870. VIPoma was first described in 1958 by American physicians, John U. Verner (endocrinologist) and Ashton B. Morrison (pathologist). VIPoma is also known as Verner-Morrison syndrome named after its discovering physicians. .<ref name="pmid24251163">{{cite journal| author=Maheshwari RR, Desai M, Rao VP, Palanki RR, Namburi RP, Reddy KT et al.| title=Ischemic stroke as a presenting feature of VIPoma due to MEN 1 syndrome. | journal=Indian J Endocrinol Metab | year= 2013 | volume= 17 | issue= Suppl 1 | pages= S215-8 | pmid=24251163 | doi=10.4103/2230-8210.119576 | pmc=PMC3830309 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24251163 }} </ref> | ||
==References== | ==References== |
Revision as of 20:34, 7 December 2017
VIPoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
VIPoma historical perspective On the Web |
American Roentgen Ray Society Images of VIPoma historical perspective |
Risk calculators and risk factors for VIPoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]Parminder Dhingra, M.D. [3]
Overview
VIPoma also known as Verner-Morrison syndrome was first described in 1958 by Verner and Morrison.[1]
Historical Perspective
The neuroendocrine tumours of the gastrointestinal tract and pancreas were discovered after Rudolf Heidenhain first found out the neuroendocrine cells in 1870. VIPoma was first described in 1958 by American physicians, John U. Verner (endocrinologist) and Ashton B. Morrison (pathologist). VIPoma is also known as Verner-Morrison syndrome named after its discovering physicians. .[1]
References
- ↑ 1.0 1.1 Maheshwari RR, Desai M, Rao VP, Palanki RR, Namburi RP, Reddy KT; et al. (2013). "Ischemic stroke as a presenting feature of VIPoma due to MEN 1 syndrome". Indian J Endocrinol Metab. 17 (Suppl 1): S215–8. doi:10.4103/2230-8210.119576. PMC 3830309. PMID 24251163.